Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07255144
Recruiting Observational

Ultrafast Ultrasound Imaging in Pediatric Cardiology

NCT07255144 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Bordeaux
Phase
Observational
Started
2025-03-11
Last updated
2025-11-28

Condition(s) studied

CHD - Congenital Heart Disease

Investigational drug(s) / intervention(s)

Cardiac Ultrafast Ultrasound

Cardiac Ultrafast Ultrasound: Ultrafast ultrasound imaging(UFUS), ultrasound images at a very high rate, using a Verasonics system (ultrasound open platform).

Study summary

About 13 in 1000 children are born with heart disease. Current tools poorly assess heart filling in children, limiting treatment. This study explores ultrafast ultrasound imaging to measure heart stiffness and perfusion in children with congenital heart disease.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Every patient of CHD department of any age or any sex: * Patients with CHD * General population patients in good general health as evidenced by medical history coming to our department for a check-up OR diagnosed with small Atrial Septal Defect or small Patent Foramen Ovale * Social security affiliation * Parental or legal guardian's non-opposition Exclusion Criteria: * Arrhythmia * Segmental kinetic disorder. * Pacemaker or multisite stimulation, defibrillator, * Anechoic * Allergy to echocardiography gel.

Primary outcome measure(s)

  • Myocardial stiffness — Baseline
    assessed with ultrasound data processed using the Verasonics system, to evaluate diastolic function
  • Myocardial perfusion — Baseline
    assessed with ultrasound data processed using the Verasonics system, to evaluate diastolic function

Trial sites (1)

FacilityCityRegionStatus
Hôpital Cardiologique Haut Lévêque Pessac France Recruiting

More University Hospital, Bordeaux trials in France

TRAnexamic Acid for Preventing Blood Loss Following a Cesarean Delivery in Women With Placenta pREVIA Recruiting
3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME) Recruiting
Post-Stroke Secondary Prevention With Digital Monitoring Recruiting
Test and Optimization of New Specific MRI Sequences on an Imager Dedicated to Research Recruiting
Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention Recruiting

Other trials for the same condition

Feasibility of Home Telemonitoring of Infants With Congenital Heart Disease Awaiting Surgery During the First Year of Life Starting soon
Brain Ultrafast Ultrasound Imaging Starting soon
Home-based Cardiovascular Rehabilitation in Young Patients With Congenital Heart Disease: the "Muscle Your Heart" Program Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07255144 on ClinicalTrials.gov ↗ ← All trials in France